Home›US Markets›Indices›Dow futures fall more than the S&P 500 on drug setback

Dow futures fall more than the S&P 500 on drug setback

The weakness is tied to a late stage setback for a Swiss cardiovascular drug.

Reported · Written up by our desk · Indices

MarketWatch reports that Dow futures underperformed the S&P 500 futures, with the difference attributed to company specific news.

The outlet links the move to a late stage setback for a cardiovascular drug from a Swiss company.

With the Dow dragged by that development, the broader index reaction is visible in the relative futures performance versus the S&P 500.

Latest closeS&P 500 7,666.60 ▲0.5%|Dow Jones 53,061.95 ▲0.6%

More like this

Sources